ESRRA |
ESRRA, ERR1, ESRL1, NR3B1: Steroid hormone receptor ERR1 |
STAT3 |
|
3.642 |
Evidence |
|
TERF2IP |
TERF2IP, RAP1, PP8000: Telomeric repeat-binding factor 2-interacting protein 1 |
STAT3 |
|
3.642 |
Evidence |
|
HIST1H1C |
HIST1H1C, H1F2: Histone H1.2 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
3.642 |
Evidence |
|
CTDP1 |
CTDP1, FCP1: RNA polymerase II subunit A C-terminal domain phosphatase |
STAT3 |
|
3.642 |
Evidence |
|
CDC7 |
CDC7, CDC7L1: Cell division cycle 7-related protein kinase |
SLC4A3 |
SLC4A3, AE3: Anion exchange protein 3 |
3.642 |
Evidence |
|
TYK2 |
TYK2: Non-receptor tyrosine-protein kinase TYK2 |
NFATC3 |
NFATC3, NFAT4: Nuclear factor of activated T-cells, cytoplasmic 3 |
3.642 |
Evidence |
|
ITGB3 |
ITGB3, GP3A: Integrin beta-3 precursor |
SGK2 |
SGK2: Serine/threonine-protein kinase Sgk2 |
3.642 |
Evidence |
|
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
PTPRR |
PTPRR, ECPTP, PTPRQ: Receptor-type tyrosine-protein phosphatase R precursor |
3.642 |
Evidence |
|
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
HNRPK |
HNRPK, HNRNPK: Heterogeneous nuclear ribonucleoprotein K |
3.642 |
Evidence |
|
PABPC4 |
PABPC4, APP1, PABP4: Polyadenylate-binding protein 4 |
AXIN1 |
|
3.642 |
Evidence |
|
RAF1 |
RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase |
GJB1 |
GJB1, CX32: Gap junction beta-1 protein |
3.642 |
Evidence |
|
TP53 |
TP53, P53: Cellular tumor antigen p53 |
LAMR1 |
RPSA, LAMBR, LAMR1: 40S ribosomal protein SA |
3.64 |
Evidence |
|
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
3.64 |
Evidence |
|
RARS |
RARS: Arginyl-tRNA synthetase, cytoplasmic |
PABPN1 |
PABPN1, PAB2, PABP2: Polyadenylate-binding protein 2 |
3.64 |
Evidence |
|
EIF2S2 |
EIF2S2, EIF2B: Eukaryotic translation initiation factor 2 subunit 2 |
QARS |
QARS: Glutaminyl-tRNA synthetase |
3.64 |
Evidence |
|
PLSCR1 |
PLSCR1: Phospholipid scramblase 1 |
RGS19 |
RGS19, GAIP, GNAI3IP: Regulator of G-protein signaling 19 |
3.64 |
Evidence |
|
GTF2B |
GTF2B, TF2B, TFIIB: Transcription initiation factor IIB |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
3.64 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
SFRS2 |
SFRS2: Splicing factor, arginine/serine-rich 2 |
3.64 |
Evidence |
|
ADRB2 |
ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
3.64 |
Evidence |
|
MAPKAPK3 |
MAPKAPK3: MAP kinase-activated protein kinase 3 |
GNAI2 |
Galphai2 protein |
3.64 |
Evidence |
|
VCP |
VCP: Transitional endoplasmic reticulum ATPase |
RELA |
RELA, NFKB3: Transcription factor p65 |
3.64 |
Evidence |
|
BRD2 |
BRD2, KIAA9001, RING3: Bromodomain-containing protein 2 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
3.64 |
Evidence |
|
DHX16 |
DHX16, DBP2, DDX16, KIAA0577: Putative pre-mRNA-splicing factor ATP-dependent RN |
CSK |
CSK: Tyrosine-protein kinase CSK |
3.64 |
Evidence |
|
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
PPP1R8 |
IPI00030383 |
3.64 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
PABPN1 |
PABPN1, PAB2, PABP2: Polyadenylate-binding protein 2 |
3.64 |
Evidence |
|